Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-08-055792
Filing Date
2008-10-02
Accepted
2008-10-02 16:03:53
Documents
2
Period of Report
2008-10-02

Document Format Files

Seq Description Document Type Size
1 v127919_6k.htm 6-K 19319
2 GRAPHIC logo.jpg GRAPHIC 22460
  Complete submission text file 0001144204-08-055792.txt   51789
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 081103532
SIC: 2834 Pharmaceutical Preparations